...
首页> 外文期刊>Journal of the American Academy of Dermatology >Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
【24h】

Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.

机译:隆突性皮肤皮肤肉瘤:临床病理,免疫组织化学,遗传学(COL1A1-PDGFB),以及低度与高度(纤维肉瘤)肿瘤的治疗研究。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is an uncommon cutaneous tumor, usually low grade, except for the fibrosarcomatous variant (DFSP-FS). OBJECTIVES: We sought to compare the clinicopathological, immunohistochemical, genetic, and therapeutic features between DFSP and DFSP-FS. METHODS: The clinicopathological features were reviewed in 63 DFSP and 12 DFSP-FS. Immunohistochemistry and multiplex reverse transcriptase-polymerase chain reaction were carried out using formalin-fixed, paraffin-embedded tissue, using specific primers for collagen type I alpha 1 (COL1A1) and platelet-derived growth factor beta (PDGFB). RESULTS: DFSP-FS was associated with tumor history longer than 5 years (P = .009), tumor size greater than 4 cm (P = .001), more stages of modified Mohs micrographic surgery (P = .005), expansive subcutaneous infiltration (P = .005), muscular invasion (P = .0001), absence of CD34 staining (P = .018), p53 positivity (P = .006), and increased proliferative activity (P = .004) compared with DFSP. The COL1A1-PDGFB fusion transcript was found in 100% DFSP-FS and 72% DFSP. No association was found between the different COL1A1-PDGFB fusion transcripts and the different histologic subtypes. Wide local excision (2 cm) was performed in 47% of cases and modified Mohs micrographic surgery in 53%. After a mean follow-up of 73 months (range 21-235), 6 patients had local recurrence (5 DFSP, 1 DFSP-FS) and one died of disease (DFSP-FS). The only factor related to local recurrence was the type of surgery (17% wide local excision vs 0% modified Mohs micrographic surgery) (P = .006). LIMITATIONS: Our study is retrospective. Prospective studies are necessary to confirm our results. CONCLUSIONS: DFSP-FS reflects tumor progression in DFSP, with larger size, particular invasive patterns, p53 expression, and increased proliferative activity. However, as in low-grade DFSP, appropriate surgery permits a tumor-free excision. COL1A1-PDGFB is a useful tool for diagnosis of DFSP and particularly for DFSP-FS.
机译:背景:隆突性皮肤皮肤肉瘤(DFSP)是一种罕见的皮肤肿瘤,除纤维肉瘤变体(DFSP-FS)外,通常为低度。目的:我们试图比较DFSP和DFSP-FS之间的临床病理,免疫组织化学,遗传和治疗特征。方法:对63例DFSP和12例DFSP-FS的临床病理特征进行了回顾。使用福尔马林固定,石蜡包埋的组织进行免疫组织化学和多重逆转录聚合酶链反应,并使用I型胶原蛋白α1(COL1A1)和血小板衍生的生长因子β(PDGFB)的特异性引物。结果:DFSP-FS与肿瘤病程超过5年(P = .009),肿瘤尺寸大于4 cm(P = .001),改良的Mohs显微摄影术分期(P = .005),皮下扩张有关与DFSP相比,浸润(P = .005),肌肉浸润(P = .0001),无CD34染色(P = .018),p53阳性(P = .006)和增高的增殖活性(P = .004) 。在100%DFSP-FS和72%DFSP中发现了COL1A1-PDGFB融合转录本。在不同的COL1A1-PDGFB融合转录本和不同的组织学亚型之间未发现关联。 47%的病例进行了广泛的局部切除(2厘米),改良的Mohs显微外科手术的病例为53%。在平均随访73个月(范围21-235)之后,有6例患者局部复发(5 DFSP,1 DFSP-FS),其中1例病死(DFSP-FS)。与局部复发相关的唯一因素是手术的类型(17%的局部切除与0%的改良Mohs显微外科手术)(P = .006)。局限性:我们的研究是回顾性的。前瞻性研究对于确认我们的结果是必要的。结论:DFSP-FS反映了DFSP中的肿瘤进展,具有较大的大小,特定的侵袭性模式,p53表达和增高的增殖活性。但是,与低度DFSP一样,适当的手术可实现无肿瘤的切除。 COL1A1-PDGFB是诊断DFSP特别是DFSP-FS的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号